Dianthus Therapeutics | MGTA - Market Capitalization

Stock Price
87.39
Daily Change
-2.43 -2.71%
Monthly
9.77%
Yearly
303.28%
Q2 Forecast
85.52

Dianthus Therapeutics reported $2.63B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
IQVIA Holdings USD 29.18B 9.2B Apr/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.67B 317.89M Apr/2026
Qiagen NV USD 9.9B 207.4M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Sartorius EUR 7.48B 6.76B Apr/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zealand Pharma A/S 33.35B 0 Apr/2026
Zz Pientze Pharmaceu CNY 86.94B 31.78B Apr/2026